VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
KURA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
KURAKura Oncology, Inc.
$10.65$945M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksKURAQuarterly Financials

Kura Oncology, Inc. (KURA) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Kura Oncology, Inc. (KURA) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

KURA Income Statement

Quarterly statement

KURA Income Statement

Kura Oncology, Inc. (KURA) annual income statement — 18-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue20.87M18.27M17.34M20.75M15.29M14.11M53.88M0000000000000
Revenue Growth %36.54%29.47%-67.83%-----------------
Cost of Goods Sold243K617K03.21M0000202K234K214K216K00000000
COGS % of Revenue1.16%3.38%-15.48%----------------
Gross Profit20.63M17.65M17.34M17.54M15.29M14.11M53.88M0-202K-234K-214K-216K00000000
Gross Margin %98.84%96.62%100%84.52%100%100%100%-------------
Gross Profit Growth %34.95%25.09%-67.83%-7668.32%6129.06%25278.97%100%------------
Operating Expenses93.64M96.46M103.6M97.53M87.95M78.81M76.34M59.88M56.2M54.22M46.55M42.26M40M36.57M35.16M36.59M35.33M32.78M33.04M33.68M
OpEx % of Revenue448.6%528.13%597.62%470.05%575.31%558.61%141.67%-------------
Selling, General & Admin31.75M31.2M39.14M32.84M25.17M22.84M24.07M18.18M16.48M17.95M14.02M12.93M11.82M11.37M12.49M11.62M11.07M11.87M12.08M11.31M
SG&A % of Revenue152.1%170.82%225.77%158.26%164.63%161.86%44.67%-------------
Research & Development61.89M65.26M64.41M67.91M62.78M55.97M52.27M41.7M39.73M36.27M32.53M29.33M28.18M25.19M22.67M24.97M24.26M20.91M20.96M22.37M
R&D % of Revenue296.5%357.31%371.53%327.27%410.68%396.75%97%-------------
Other Operating Expenses0057K-1000K0000000000000000
Operating Income-73.01M-78.81M-86.27M-80M-72.67M-64.7M-22.45M-59.88M-56.4M-54.45M-46.76M-42.47M-40M-36.57M-35.16M-36.59M-35.33M-32.78M-33.04M-33.68M
Operating Margin %-349.77%-431.51%-497.62%-385.53%-475.31%-458.61%-41.67%-------------
Operating Income Growth %-0.47%-21.82%-284.18%-33.59%-28.83%-18.82%51.98%-40.99%-41%-48.91%-33.01%-16.07%-13.22%-11.54%-6.41%-8.66%-5.01%-6.1%-25.47%-39.2%
EBITDA-70.64M-78.46M-85.86M-79.83M-72.44M-64.46M-22.25M-59.68M-56.2M-54.22M-46.55M-42.26M-39.79M-36.36M-34.95M-36.4M-35.15M-32.6M-32.87M-33.52M
EBITDA Margin %-338.44%-429.56%-495.3%-384.74%-473.85%-456.9%-41.3%-------------
EBITDA Growth %2.48%-21.72%-285.89%-33.78%-28.9%-18.89%52.2%-41.22%-41.25%-49.11%-33.18%-16.09%-13.2%-11.52%-6.32%-8.6%-4.85%-5.9%-25.35%-38.96%
D&A (Non-Cash Add-back)2.37M355K403K164K224K241K204K208K202K234K214K216K213K206K206K193K183K177K166K160K
EBIT-67.98M-72.99M-80.58M-74.12M-65.73M-57.59M-16.8M-53.99M-50.43M-49.13M-42.39M-38.2M-36.79M-33.7M-32.88M-35.5M-34.77M-32.45M-32.74M-33.37M
Net Interest Income-345K5.49M5.34M5.88M6.54M7.5M5.26M5.48M5.57M4.93M3.98M3.87M2.83M2.5M2.04M1.09M564K329K295K311K
Interest Income05.83M5.69M6.27M6.93M7.88M5.66M5.89M5.97M5.33M4.37M4.28M3.22M2.86M2.27M1.09M564K329K295K311K
Interest Expense345K336K346K393K391K382K403K412K406K398K394K404K387K364K229K00000
Other Income/Expense4.69M5.49M5.34M5.88M6.54M7.5M5.26M5.48M5.57M4.93M3.98M3.87M2.83M2.5M2.04M1.09M564K329K295K311K
Pretax Income-68.32M-73.33M-80.93M-74.12M-66.12M-57.2M-17.2M-54.4M-50.84M-49.52M-42.79M-38.6M-37.17M-34.07M-33.11M-35.5M-34.77M-32.45M-32.74M-33.37M
Pretax Margin %-327.31%-401.45%-466.82%-357.19%-432.51%-405.46%-31.92%-------------
Income Tax5K8K71K00226K2.02M0000000000000
Effective Tax Rate %-0.01%-0.01%-0.09%0%0%-0.4%-11.73%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-68.33M-73.33M-81M-74.12M-66.12M-57.43M-19.22M-54.4M-50.84M-49.52M-42.79M-38.6M-37.17M-34.07M-33.11M-35.5M-34.77M-32.45M-32.74M-33.37M
Net Margin %-327.33%-401.49%-467.23%-357.19%-432.51%-407.07%-35.66%-------------
Net Income Growth %-3.33%-27.69%-321.5%-36.23%-30.07%-15.96%55.09%-40.94%-36.75%-45.37%-29.21%-8.73%-6.92%-4.98%-1.13%-6.41%-3.29%-5.73%-25.17%-40.38%
Net Income (Continuing)-68.33M-73.33M-81M-74.12M-66.12M-57.43M-19.22M-54.4M-50.84M-49.52M-42.79M-38.6M-37.17M-34.07M-33.11M-35.5M-34.77M-32.45M-32.74M-33.37M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.77-0.83-0.92-0.85-0.75-0.66-0.22-0.63-0.59-0.59-0.55-0.50-0.53-0.50-0.49-0.53-0.52-0.49-0.49-0.50
EPS Growth %-2.67%-25.76%-318.18%-34.92%-27.12%-11.86%60%-26%-11.32%-18%-12.24%5.66%-1.92%-2.04%0%-6%-1.96%-6.52%-8.89%-19.05%
EPS (Basic)-0.77-0.83-0.92-0.85-0.75-0.66-0.22-0.63-0.59-0.59-0.55-0.50-0.53-0.50-0.49-0.53-0.52-0.49-0.49-0.50
Diluted Shares Outstanding88.86M88.61M88.05M87.64M87.59M87.42M87.14M86.95M86.64M83.91M77.34M77.24M69.8M68.4M67.78M66.89M66.67M66.61M66.55M66.35M
Basic Shares Outstanding88.86M88.61M88.05M87.65M87.59M87.42M87.14M86.95M86.64M83.91M77.34M77.24M69.8M68.4M67.78M66.89M66.67M66.61M66.55M66.35M
Dividend Payout Ratio--------------------